Last Updated：2025/11/28
In a clinical trial, ipenoxazone showed promise by reducing neuronal damage after ischemic stroke through its action as a glutamate antagonist.
See correct answer
In a clinical trial, ipenoxazone showed promise by reducing neuronal damage after ischemic stroke through its action as a glutamate antagonist.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
